VIDEO: COVID-19 bivalent booster ‘strongly recommended’ for patients with IBD
Click Here to Manage Email Alerts
In a Healio video exclusive, Freddy Caldera, DO, MS, urged providers to recommend the COVID-19 booster vaccine to all patients with inflammatory bowel disease.
“Throughout the COVID-19 pandemic, we have learned a lot about the impact of medicines that patients with IBD use and their risks for COVID-19,” Caldera, associate professor of medicine in the division of gastroenterology and hepatology at the University of Wisconsin School of Medicine, said. “We know that we have good data from secure and international registries that patients with IBD are not at increased risk for severe COVID or their complications. We also have a lot of good data also on the vaccine response in patients with IBD.
“It’s time for a new COVID-19 vaccine 2.0, where the new bivalent booster is available for everyone 12 years and up, that is recommended for all patients with IBD,” he noted. “It is also safe to take along with your influenza vaccine. This is definitely something you should be strongly recommending to your patients because we have seen an uptick in hospitalization, especially in adults 65 years and above, and we know that COVID-19 can be associated with cardiovascular complications.”
Collapse
Healio Interviews
Read more about
Click Here to Manage Email Alerts